- Home
- AXS vs TECH Comparison
AXS vs TECH Comparison
Compare AXS & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXS | TECH |
|---|---|---|
| Founded | 2001 | 1976 |
| Country | Bermuda | United States |
| Employees | 1876 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 10.2B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | AXS | TECH |
|---|---|---|
| Price | $100.46 | $51.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $121.86 | $73.09 |
| AVG Volume (30 Days) | 609.0K | ★ 2.1M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 1.76% | 0.60% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $1,219,635,000.00 |
| Revenue This Year | $4.36 | $2.49 |
| Revenue Next Year | $6.20 | $6.40 |
| P/E Ratio | ★ $8.43 | $109.66 |
| Revenue Growth | N/A | ★ 5.23 |
| 52 Week Low | $84.81 | $46.02 |
| 52 Week High | $110.34 | $72.16 |
Technical Indicators
Market Signals| Indicator | AXS | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 40.79 | 32.01 |
| Support Level | $99.15 | $48.93 |
| Resistance Level | $103.65 | $54.08 |
| Average True Range (ATR) | 2.32 | 2.46 |
| MACD | -0.49 | -0.38 |
| Stochastic Oscillator | 20.49 | 19.76 |
Price Performance
Historical ComparisonAbout AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.